Artículos de revistas
Impact of psychiatric disorders on the quality of life of brazilian HCV-infected patients
Fecha
2009-02-01Registro en:
Brazilian Journal of Infectious Diseases. Brazilian Society of Infectious Diseases, v. 13, n. 1, p. 40-43, 2009.
1413-8670
S1413-86702009000100009.pdf
S1413-86702009000100009
10.1590/S1413-86702009000100009
WOS:000267703200009
Autor
Batista-Neves, Susana
Quarantini, Lucas de Castro
Almeida, Amanda Cristina Galvão Oliveira de
Cardeal, Maurício
Lacerda, Acioly Luiz Tavares de
Paraná, Raymundo
Reis De-Oliveira, Irismar
Bressan, Rodrigo Affonseca
Miranda-Scippa, Ângela Marisa de Aquino
Institución
Resumen
The aim of our study was to determine the impact of psychiatric comorbidities on the health-related quality of life of HCV-infected patients. Assessment of clinical, socio-demographic and quality of life data of the patients followed up at a Hepatology unit was performed by using a standard questionnaire and the SF-36 instrument. Psychiatric diagnoses were confirmed by using the Mini International Neuropsychiatric Interview, Brazilian version 5.0.0 (MINI Plus). Evaluation using the MINI plus demonstrated that 46 (51%) patients did not have any psychiatric diagnosis, while 44 (49%) had at least one psychiatric diagnosis. Among patients with a psychiatric comorbidity, 26 (59.1%) had a current mental disorder, out of which 22 (84.6%) had not been previously diagnosed. Patients with psychiatric disorders had lower scores in all dimensions of the SF-36 when compared to those who had no psychiatric diagnosis. Scores of physical functioning and bodily pain domains were lower for those suffering from a current psychiatric disorder when compared to those who had had a psychiatric disorder in the past. Females had lower scores of bodily pain and mental health dimensions when compared to males. Scores for mental health dimension were also lower for patients with advanced fibrosis. The presence of a psychiatric comorbidity was the variable that was most associated with the different scores in the SF-36, compared to other variables such as age, gender, aminotransferase levels, and degree of fibrosis.